- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Smc1a KO Mouse Model
| Strain Name | Smc1a KO Mouse Model |
|---|---|
| Editing Type | Knockout |
| Gene Name | Smc1a (mouse structural maintenance of chromosomes 1A) |
| Gene Synonyms | Smc1 / Smcb / Sb1.8 / SMC-1A / Smc1l1 / Smc1alpha / mKIAA0178 |
| Strain Background | C57BL/6N |
| NCBI No. | Gene ID: 24061 / MGI:1344345 |

1. Cohesinopathy mechanism research Investigating the role of Smc1a deficiency in the pathogenesis of Cornelia de Lange syndrome and other cohesinopathies; evaluating how loss of the cohesin SMC1A subunit affects chromosome cohesion, sister chromatid separation and genomic stability.
2. Embryonic development and organogenesis Exploring the critical functions of Smc1a during early embryonic development and organ formation; studying the developmental defects, growth retardation and multi-system developmental abnormalities that result from Smc1a deficiency.
3. Neurodevelopment and function Investigating the effects of Smc1a deficiency on nervous system development, neuronal migration, synapse formation and cognitive function; assessing the utility of Smc1a KO mice for modelling neurodevelopmental disorders such as autism spectrum disorder and intellectual disability.
4. Tumorigenesis and DNA damage response Studying the role of Smc1a in maintaining genomic stability, DNA damage repair and cell cycle regulation; evaluating how Smc1a deficiency affects tumor susceptibility, cell proliferation and apoptosis.
The Smc1a Knockout Mouse Model is generated by gene editing to produce a systemic knockout of the Smc1a gene. SMC1A is a core subunit of the cohesin complex, which plays essential roles in sister chromatid cohesion, chromosome segregation, DNA damage repair and transcriptional regulation. Loss of Smc1a results in embryonic lethality or severe developmental defects, reproducing key features of human cohesinopathies such as Cornelia de Lange syndrome. The model supports in vivo dissection of SMC1A function in embryonic development, organogenesis, neurodevelopment and genomic stability, sheds light on the molecular mechanisms through which cohesin dysfunction produces disease, and provides a preclinical platform for evaluating gene therapy and pharmacological intervention strategies. Conditional and tissue-specific knockout configurations are available on request.
- A clean genetic baseline for cohesin biology. Cohesin has four core subunits; removing SMC1A isolates the complex’s defect without a second, unrelated lesion in the background.
- Disease-matched, not disease-adjacent. SMC1A is the gene behind Cornelia de Lange syndrome type 2 in humans, so the model speaks to a defined clinical entity rather than a generic developmental phenotype.
- Early lethality is informative, not a limitation. Because loss is embryonic lethal, the line defines which processes are strictly cohesin-dependent — and gives a controlled setting for asking which functions are separable.
- CNS-early expression, measured. CNS E11.5 RPKM 47.7 is the highest value across 29 tissues, which is exactly where the neurodevelopmental questions sit.
- Configurable. Conditional and tissue-specific knockouts can be requested, so the embryonic-lethal constraint can be bypassed for adult-tissue work.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
